Nuance Communications, Inc. is a provider of voice recognition and natural language understanding solutions. The company has market cap of $4.70 billion. The Company’s divisions include Healthcare, Mobile, Enterprise and Imaging. It currently has negative earnings. The Healthcare segment provides clinical speech and clinical language understanding solutions.
Cyclacel Pharmaceuticals Inc (CYCC) formed multiple bottom with $5.52 target or 6.00% below today’s $5.87 share price. Cyclacel Pharmaceuticals Inc (CYCC) has $24.05M valuation. The stock decreased 4.08% or $0.25 on April 13, reaching $5.87. About shares traded. Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) has risen 8.50% since September 8, 2016 and is uptrending. It has outperformed by 1.73% the S&P500.
The stock decreased 1.56% or $0.26 on April 13, reaching $16.38. About shares traded. Nuance Communications Inc. (NASDAQ:NUAN) has risen 10.30% since September 8, 2016 and is uptrending. It has outperformed by 3.53% the S&P500.
Ratings analysis reveals 89% of Nuance Communications’s analysts are positive. Out of 9 Wall Street analysts rating Nuance Communications, 8 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $17 while the high is $30. The stock’s average target of $21.50 is 31.26% above today’s ($16.38) share price. NUAN was included in 20 notes of analysts from August 7, 2015. The stock of Nuance Communications Inc. (NASDAQ:NUAN) has “Neutral” rating given on Tuesday, August 9 by UBS. On Tuesday, November 17 the stock rating was maintained by Oppenheimer with “Outperform”. The firm earned “Buy” rating on Wednesday, May 11 by Canaccord Genuity. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, November 17. Standpoint Research upgraded the shares of NUAN in report on Friday, January 15 to “Buy” rating. Barclays Capital initiated Nuance Communications Inc. (NASDAQ:NUAN) on Friday, April 15 with “Equal-Weight” rating. The stock has “Outperform” rating by Leerink Swann on Wednesday, May 11. The rating was upgraded by Raymond James on Friday, November 18 to “Strong Buy”. Canaccord Genuity maintained Nuance Communications Inc. (NASDAQ:NUAN) on Friday, August 7 with “Buy” rating. The firm earned “Outperform” rating on Wednesday, September 9 by Leerink Swann.
Analysts await Nuance Communications Inc. (NASDAQ:NUAN) to report earnings on May, 9. They expect $0.26 EPS, up 4.00% or $0.01 from last year’s $0.25 per share. NUAN’s profit will be $74.60 million for 15.75 P/E if the $0.26 EPS becomes a reality. After $0.21 actual EPS reported by Nuance Communications Inc. for the previous quarter, Wall Street now forecasts 23.81% EPS growth.
Shannon River Fund Management Llc holds 3.91% of its portfolio in Nuance Communications Inc. for 842,367 shares. Sg Capital Management Llc owns 1.08 million shares or 2.68% of their US portfolio. Moreover, Mcrae Capital Management Inc has 2.07% invested in the company for 314,600 shares. The Pennsylvania-based Millrace Asset Group Inc. has invested 2.03% in the stock. Fairpointe Capital Llc, a Illinois-based fund reported 5.81 million shares.
Since January 1, 0001, it had 0 buys, and 20 selling transactions for $2.85 million activity.
Investors sentiment is 0 in 2016 Q4. Its the same as in 2016Q3. It has no change, as 0 investors sold Cyclacel Pharmaceuticals Inc shares while 1 reduced holdings. only 0 funds opened positions while 0 raised stakes. 13,286 shares or 2.21% less from 13,586 shares in 2016Q3 were reported. Tower Rech Cap Ltd Limited Liability Company (Trc) has 33 shares for 0% of their portfolio. Baker Bros Limited Partnership invested in 0% or 13,253 shares.
